Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study
- PMID: 24335384
- PMCID: PMC3927975
- DOI: 10.1093/aje/kwt299
Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study
Abstract
We examined racial differences in gout incidence among black and white participants in a longitudinal, population-based cohort and tested whether racial differences were explained by higher levels of serum urate. The Atherosclerosis Risk in Communities Study is a prospective, US population-based cohort study of middle-aged adults enrolled between 1987 and 1989 with ongoing annual follow-up through 2012. We estimated the adjusted hazard ratios and 95% confidence intervals of incident gout by race among 11,963 men and women using adjusted Cox proportional hazards models. The cohort was 23.6% black. The incidence rate of gout was 8.4 per 10,000 person-years (15.5/10,000 person-years for black men, 12.0/10,000 person-years for black women, 9.4/10,000 person-years for white men, and 5.0/10,000 person-years for white women; P < 0.001). Black participants had an increased risk of incident gout (for women, adjusted hazard ratio (HR) = 1.69, 95% confidence interval (CI): 1.29, 2.22; for men, adjusted HR = 1.92, 95% CI: 1.44, 2.56). Upon further adjustment for uric acid levels, there was modest attenuation of the association of race with incident gout (for women, adjusted HR = 1.62, 95% CI: 1.24, 2.22; for men, adjusted HR = 1.49, 95% CI: 1.11, 2.00) compared with white participants. In this US population-based cohort, black women and black men were at increased risk of developing gout during middle and older ages compared with whites, which appears, particularly in men, to be partly related to higher urate levels in middle-aged blacks.
Keywords: gout; inflammatory arthritis; race; uric acid.
Figures



Similar articles
-
Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort.J Clin Hypertens (Greenwich). 2012 Oct;14(10):675-9. doi: 10.1111/j.1751-7176.2012.00674.x. Epub 2012 Jun 13. J Clin Hypertens (Greenwich). 2012. PMID: 23031144 Free PMC article.
-
A comparative analysis of risk factors for stroke in blacks and whites: the Atherosclerosis Risk in Communities study.Ethn Health. 2014;19(6):601-16. doi: 10.1080/13557858.2013.857765. Epub 2013 Nov 21. Ethn Health. 2014. PMID: 24261746 Free PMC article.
-
Association of race and sex with risk of incident acute coronary heart disease events.JAMA. 2012 Nov 7;308(17):1768-74. doi: 10.1001/jama.2012.14306. JAMA. 2012. PMID: 23117777 Free PMC article.
-
Stroke incidence and mortality trends in US communities, 1987 to 2011.JAMA. 2014 Jul 16;312(3):259-68. doi: 10.1001/jama.2014.7692. JAMA. 2014. PMID: 25027141
-
Association between urinary albumin excretion and coronary heart disease in black vs white adults.JAMA. 2013 Aug 21;310(7):706-14. doi: 10.1001/jama.2013.8777. JAMA. 2013. PMID: 23989654 Free PMC article.
Cited by
-
Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study.Hypertension. 2020 Jan;75(1):246-256. doi: 10.1161/HYPERTENSIONAHA.119.13580. Epub 2019 Dec 2. Hypertension. 2020. PMID: 31786980 Free PMC article.
-
A meta-analysis of the associations between the Q141K and Q126X ABCG2 gene variants and gout risk.Int J Clin Exp Pathol. 2015 Sep 1;8(9):9812-23. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26617691 Free PMC article.
-
One size does not fit all: understanding individual living kidney donor risk.Pediatr Nephrol. 2021 Feb;36(2):259-269. doi: 10.1007/s00467-019-04456-8. Epub 2020 Jan 2. Pediatr Nephrol. 2021. PMID: 31897715 Free PMC article. Review.
-
Epidemiology and management of gout in Taiwan: a nationwide population study.Arthritis Res Ther. 2015 Jan 23;17(1):13. doi: 10.1186/s13075-015-0522-8. Arthritis Res Ther. 2015. PMID: 25612613 Free PMC article.
-
The Dietary Fructose:Vitamin C Intake Ratio Is Associated with Hyperuricemia in African-American Adults.J Nutr. 2018 Mar 1;148(3):419-426. doi: 10.1093/jn/nxx054. J Nutr. 2018. PMID: 29546301 Free PMC article.
References
-
- Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011;63(10):3136–3141. - PubMed
-
- Krishnan E, Lienesch D, Kwoh CK. Gout in ambulatory care settings in the United States. J Rheumatol. 2008;35(3):498–501. - PubMed
-
- Sundy JS, Hershfield MS. Uricase and other novel agents for the management of patients with treatment-failure gout. Curr Rheumatol Rep. 2007;9(3):258–264. - PubMed
-
- Halpern R, Mody RR, Fuldeore MJ, et al. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis. Curr Med Res Opin. 2009;25(7):1711–1719. - PubMed
-
- Halpern R, Fuldeore MJ, Mody RR, et al. The effect of serum urate on gout flares and their associated costs: an administrative claims analysis. J Clin Rheumatol. 2009;15(1):3–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HHSN268201100012C/HL/NHLBI NIH HHS/United States
- HHSN268201100009I/HL/NHLBI NIH HHS/United States
- HHSN268201100010C/HL/NHLBI NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- HHSN268201100011I/HL/NHLBI NIH HHS/United States
- HHSN268201100011C/HL/NHLBI NIH HHS/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- HHSN268201100005I/HL/NHLBI NIH HHS/United States
- HHSN268201100007I/HL/NHLBI NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- HHSN268201100005G/HL/NHLBI NIH HHS/United States
- HHSN268201100008I/HL/NHLBI NIH HHS/United States
- HHSN268201100009C/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical